pmid	doi	year	title	Hugo_Symbol
33297669	10.3324/haematol.2020.267294	2022	Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas.	STAT3
33579790	10.1136/gutjnl-2020-322935	2022	Oncogenetic landscape of lymphomagenesis in coeliac disease.	STAT3
33944901	10.1093/asj/sjab215	2022	Nonmalignant CD30+ Cells in Contralateral Peri-Implant Capsule of Patient With BIA-ALCL: A Premalignant Step?	STAT3
34380908	10.4103/1673-5374.320991	2022	Krüppel-like factor 7 attenuates hippocampal neuronal injury after traumatic brain injury.	STAT3
34503423	10.2174/1871520621666210908103306	2022	The Acetyltransferase KAT5 Inhibitor NU 9056 Promotes Apoptosis and Inhibits JAK2/STAT3 Pathway in Extranodal NK/T Cell Lymphoma.	STAT3
34520436	10.1097/CAD.0000000000001249	2022	Sensitivity of eight types of ALK fusion variant to alectinib in ALK-transformed cells.	STAT3
34528236	10.1111/bjd.20760	2022	Transcriptomic changes during stage progression of mycosis fungoides.	STAT3
34587248	10.1182/blood.2021012976	2022	Genome-wide CRISPR-Cas9 screen identifies rationally designed combination therapies for CRLF2-rearranged Ph-like ALL.	STAT3
34657149	10.1182/blood.2020008136	2022	Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma.	STAT3
34687742	10.1016/j.jid.2021.09.024	2022	PLCγ1/PKCθ Downstream Signaling Controls Cutaneous T-Cell Lymphoma Development and Progression.	STAT3
34714908	10.1182/bloodadvances.2021005486	2022	Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways.	STAT3
34743203	10.1038/s41418-021-00880-2	2022	Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-β-catenin-STAT3 signaling.	STAT3
34818414	10.1182/blood.2021012734	2022	Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma.	STAT3
34862350	10.1097/MPH.0000000000002364	2022	Management of Peripheral T-Cell Lymphoma in Children and Adolescents Including STAT 3 Mutation Hyper-IgE Syndrome: One Size Does Not Fit All.	STAT3
34915482	10.1159/000521445	2022	STAT3 Promotes Cell Proliferation by Potentiating the CCL4 Transcriptional Activity in Diffuse Large B-Cell Lymphoma.	STAT3
34917911	10.1016/j.jhepr.2021.100386	2022	ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis.	STAT3
34922904	10.1016/j.cbi.2021.109779	2022	Diffuse large B-cell lymphoma-derived exosomes push macrophage polarization toward M2 phenotype via GP130/STAT3 signaling pathway.	STAT3
34977845	10.1016/j.xjidi.2021.100068	2022	Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders.	STAT3
35014680	10.3892/mmr.2022.12592	2022	Role of TGM2 in T‑cell lymphoblastic lymphoma via regulation of IL‑6/JAK/STAT3 signalling.	STAT3
35021606	10.3324/haematol.2021.280003	2022	Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS.	STAT3
35059947	10.1007/s10875-021-01197-y	2022	Malignancy in STAT3 Deficient Hyper IgE Syndrome.	STAT3
35085771	10.1016/j.cellsig.2022.110264	2022	EML4-ALK G1202R mutation induces EMT and confers resistance to ceritinib in NSCLC cells via activation of STAT3/Slug signaling.	STAT3
35100463	10.1111/cas.15277	2022	Inhibition of adult T-cell leukemia cell proliferation by polymerized proanthocyanidin from blueberry leaves through JAK proteolysis.	STAT3
35133054	10.1111/cas.15296	2022	Downregulation of miR-26 promotes invasion and metastasis via targeting interleukin-22 in cutaneous T-cell lymphoma.	STAT3
35136485	10.18632/oncotarget.28189	2022	GZ17-6.02 and axitinib interact to kill renal carcinoma cells.	STAT3
35189357	10.1016/j.phrs.2022.106134	2022	Expanding the armory for treating lymphoma: Targeting redox cellular status through thioredoxin reductase inhibition.	STAT3
35199089	10.1016/j.xjidi.2021.100084	2022	Malignant T Cell Activation by a <i>Bacillus</i> Species Isolated from Cutaneous T-Cell Lymphoma Lesions.	STAT3
35228642	10.1038/s41698-022-00254-y	2022	STAT3 inhibition suppresses adaptive survival of ALK-rearranged lung cancer cells through transcriptional modulation of apoptosis.	STAT3
35249489	10.2174/1568009622666220304202116	2022	Novel Compound, ND-17, Regulates the JAK/STAT, PI3K/AKT, and MAPK Pathways and Restrains Human T-lymphoid Leukemia Development.	STAT3
35279012	10.1016/j.biopha.2022.112800	2022	The multifaceted mechanisms of Paeoniflorin in the treatment of tumors: State-of-the-Art.	STAT3
35340094	10.1111/vco.12816	2022	Anticancer activity of IRAK-4 inhibitors against canine lymphoid malignancies.	STAT3
35359405	10.3389/fonc.2022.842356	2022	Fbw7 Inhibits the Progression of Activated B-Cell Like Diffuse Large B-Cell Lymphoma by Targeting the Positive Feedback Loop of the LDHA/lactate/miR-223 Axis.	STAT3
35366115	10.1007/s00428-022-03309-4	2022	Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation.	STAT3
35395970	10.19746/j.cnki.issn.1009-2137.2022.02.013	2022	[Expression Level of SOCS3 in Acute Lymphoblastic Leukemia Cells Affects the Cytotoxicity of NK Cells].	STAT3
35411036	10.1038/s41388-022-02301-1	2022	Novel TENM3-ALK fusion is an alternate mechanism for ALK activation in neuroblastoma.	STAT3
35438417	10.1007/s10875-022-01269-7	2022	Correction to: Malignancy in STAT3 Deficient Hyper IgE Syndrome.	STAT3
35439335	10.1002/hon.3007	2022	The potential efficacy and mechanism of bendamustine in entra-nodal NK/T cell lymphoma.	STAT3
35474053	10.1007/s11033-022-07399-w	2022	STAT signaling as a target for intervention: from cancer inflammation and angiogenesis to non-coding RNAs modulation.	STAT3
35477814	10.1007/s10637-022-01250-6	2022	Exportin-1 is critical for cell proliferation and survival in adult T cell leukemia.	STAT3
35484662	10.3324/haematol.2021.279957	2022	Resistance to PI3κδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis.	STAT3
35489748	10.21873/anticanres.15709	2022	Dimethyl Fumarate Induces Apoptosis <i>via</i> Inhibiting NF-κB and STAT3 Signaling in Adult T-cell Leukemia/Lymphoma Cells.	STAT3
35501257	10.1016/j.clml.2022.04.002	2022	Indolent Lymphoproliferative T-Cell Disorders Associated With Gastrointestional Disease: Diagnostic Challenges and Outcomes.	STAT3
35557592	10.21037/jgo-22-237	2022	miRNA-320 inhibits colitis-associated colorectal cancer by regulating the IL-6R/STAT3 pathway in mice.	STAT3
35578798	10.1002/jcp.30777	2022	Neddylation inactivation affects cell cycle and apoptosis in sheep follicular granulosa cells.	STAT3
35579082	10.1111/cas.15402	2022	CircPCBP2 promotes the stemness and chemoresistance of DLBCL via targeting miR-33a/b to disinhibit PD-L1.	STAT3
35600392	10.3389/fonc.2022.881801	2022	SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer.	STAT3
35640677	10.1016/j.ajpath.2022.05.005	2022	Induction of Transcriptional Inhibitor HES1 and the Related Repression of Tumor-Suppressor TXNIP Are Important Components of Cell-Transformation Program Imposed by Oncogenic Kinase NPM-ALK.	STAT3
35642002	10.1186/s12967-022-03451-2	2022	Role of chemokine-mediated angiogenesis in resistance towards crizotinib and its reversal by anlotinib in EML4-ALK positive NSCLC.	STAT3
35651609	10.3389/fimmu.2022.878989	2022	Hyper-IgE and Carcinoma in CADINS Disease.	STAT3
35671182	10.1097/CM9.0000000000001916	2022	Hepatocyte growth factor protects pulmonary endothelial barrier against oxidative stress and mitochondria-dependent apoptosis.	STAT3
35697790	10.1038/s41375-022-01623-z	2022	Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer/T-cell lymphoma.	STAT3
35743211	10.3390/ijms23126773	2022	Mechanisms of Sensitivity and Resistance of Primary Effusion Lymphoma to Dimethyl Fumarate (DMF).	STAT3
35752777	10.1186/s12860-022-00422-9	2022	Evaluation of the putative lymphoma-associated point mutation D427H in the STAT3 transcription factor.	STAT3
35790291	10.21873/anticanres.15823	2022	SOCS1 Gene Therapy for Head and Neck Cancers: An Experimental Study.	STAT3
35803438	10.1016/j.taap.2022.116156	2022	1-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)-3-(2-(dimethylamino)ethyl)imidazolidin-2-one (ZX-42) inhibits cell proliferation and induces apoptosis via inhibiting ALK and its downstream pathways in Karpas299 cells.	STAT3
35805156	10.3390/cells11132072	2022	Phospho-Specific Flow Cytometry Reveals Signaling Heterogeneity in T-Cell Acute Lymphoblastic Leukemia Cell Lines.	STAT3
35879049	10.1136/gutjnl-2021-326257	2022	Immunopathogenesis and environmental triggers in coeliac disease.	STAT3
35882439	10.1182/bloodadvances.2022007541	2022	Genetic and immunohistochemical profiling of NK/T-cell Lymphomas reveals prognostically relevant BCOR-MYC association.	STAT3
35884913	10.3390/biomedicines10071608	2022	Downregulation of STAT3 in Epstein-Barr Virus-Positive Hodgkin Lymphoma.	STAT3
35897737	10.3390/ijms23158161	2022	The Pt(<i>S</i>-pr-thiosal)2 and BCL1 Leukemia Lymphoma: Antitumor Activity In Vitro and In Vivo.	STAT3
35903524	10.1016/j.jsps.2022.05.009	2022	Genistein promotes M1 macrophage apoptosis and reduces inflammatory response by disrupting miR-21/TIPE2 pathway.	STAT3
35917766	10.1016/j.bmc.2022.116936	2022	Design, synthesis and in vitro biological evaluation of marine phidianidine derivatives as potential anti-inflammatory agents.	STAT3
35973920	10.1016/j.jcyt.2022.06.007	2022	Human gingival mesenchymal stem cells improve movement disorders and tyrosine hydroxylase neuronal damage in Parkinson disease rats.	STAT3
35990641	10.3389/fimmu.2022.937872	2022	Genomic crossroads between non-Hodgkin's lymphoma and common variable immunodeficiency.	STAT3
35994220	10.1007/s12013-022-01088-y	2022	Effects of STAT3 Inhibitor BP-1-102 on The Proliferation, Invasiveness, Apoptosis and Neurosphere Formation of Glioma Cells in Vitro.	STAT3
36035991	10.3389/fcell.2022.935023	2022	Protein Kinase CK2 represents a new target to boost Ibrutinib and Venetoclax induced cytotoxicity in mantle cell lymphoma.	STAT3
36045346	10.1186/s12943-022-01640-7	2022	PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma.	STAT3
36064579	10.1038/s41388-022-02453-0	2022	ALK fusion promotes metabolic reprogramming of cancer cells by transcriptionally upregulating PFKFB3.	STAT3
36086962	10.15586/aei.v50i5.626	2022	Deoxyelephantopin alleviates lipopolysaccharide-induced septic lung injury through inhibiting NF-ĸB/STAT3 axis.	STAT3
32270320	10.1007/s00403-020-02062-5	2021	The polymorphisms of IL-6/STAT3 signaling pathway may contribute to cutaneous T-cell lymphomas susceptibility.	STAT3
32273478	10.3324/haematol.2020.251579	2021	Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma.	STAT3
32327503	10.3324/haematol.2019.238766	2021	Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target.	STAT3
32619110	10.1080/10520295.2020.1770332	2021	Silencing Stat3 inhibits viability and induces apoptosis in BGC-823 human gastric cancer cell line.	STAT3
32780548	10.1111/cbdd.13778	2021	Alantolactone induces apoptosis in THP-1 cells through STAT3, survivin inhibition, and intrinsic apoptosis pathway.	STAT3
32822082	10.1002/ptr.6842	2021	MicroRNA216b mediated downregulation of HSP27/STAT3/AKT signaling is critically involved in lambertianic acid induced apoptosis in human cervical cancers.	STAT3
32961552	10.1182/blood.2020007507	2021	Mutational landscape of gray zone lymphoma.	STAT3
32985300	10.1080/10428194.2020.1817431	2021	Increased myeloid-derived suppressor cells in patients with myelodysplastic syndromes suppress CD8+ T lymphocyte function through the STAT3-ARG1 pathway.	STAT3
33079297	10.1007/s10014-020-00386-8	2021	Clinicopathologic significance of MYD88 L265P mutation and expression of TLR4 and P-STAT3 in primary central nervous system diffuse large B-cell lymphomas.	STAT3
33080566	10.1016/j.phymed.2020.153366	2021	Effect of the isoflavone corylin from cullen corylifolium on colorectal cancer growth, by targeting the STAT3 signaling pathway.	STAT3
33158639	10.1016/j.ejso.2020.10.029	2021	Biological and genetic landscape of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).	STAT3
33184494	10.1038/s41375-020-01088-y	2021	A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma.	STAT3
33223115	10.1016/j.jep.2020.113514	2021	Ethyl acetate extract of Tibetan medicine Rhamnella gilgitica ameliorated type II collagen-induced arthritis in rats via regulating JAK-STAT signaling pathway.	STAT3
33247178	10.1038/s41375-020-01093-1	2021	STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma.	STAT3
33247999	10.1111/cas.14752	2021	Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer.	STAT3
33307035	10.1016/j.ajpath.2020.12.001	2021	PIM Kinases Promote Survival and Immune Escape in Primary Mediastinal Large B-Cell Lymphoma through Modulation of JAK-STAT and NF-κB Activity.	STAT3
33310759	10.26508/lsa.202000794	2021	Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK-driven lymphomagenesis.	STAT3
33333215	10.1016/j.gene.2020.145354	2021	Puerarin alleviates coronary heart disease via suppressing inflammation in a rat model.	STAT3
33367520	10.1093/asj/sjaa398	2021	Analysis of the Molecular Signature of Breast Implant-Associated Anaplastic Large Cell Lymphoma in an Asian Patient.	STAT3
33370049	10.1097/PRS.0000000000007423	2021	Cellular and Molecular Mechanisms of Breast Implant-Associated Anaplastic Large Cell Lymphoma.	STAT3
33389078	10.1007/s00432-020-03446-w	2021	Vincristine upregulates PD-L1 and increases the efficacy of PD-L1 blockade therapy in diffuse large B-cell lymphoma.	STAT3
33393492	10.1172/JCI142627	2021	Doubling up on function: dual-specificity tyrosine-regulated kinase 1A (DYRK1A) in B cell acute lymphoblastic leukemia.	STAT3
33393494	10.1172/JCI135937	2021	DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3.	STAT3
33410350	10.1080/10428194.2020.1869964	2021	<i>STAT3</i> and <i>STAT5B</i> mutations have unique distribution in T-cell large granular lymphocyte proliferations and advanced myeloid neoplasms.	STAT3
33418509	10.1016/j.ebiom.2020.103191	2021	Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling.	STAT3
33466582	10.3390/cancers13020280	2021	JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL).	STAT3
33512408	10.1182/blood.2020005964	2021	TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target.	STAT3
33512451	10.1182/blood.2020006721	2021	Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.	STAT3
33513694	10.3390/biomedicines9020118	2021	IRE1 Alpha/XBP1 Axis Sustains Primary Effusion Lymphoma Cell Survival by Promoting Cytokine Release and STAT3 Activation.	STAT3
33529679	10.1016/j.fct.2021.112031	2021	Methylgerambullin derived from plant Glyccsmis pentaphylla (Retz) correa. Mediates anti-hepatocellular carcinoma cancer effect by activating mitochondrial and endoplasmic reticulum stress signaling and inhibiting AKT and STAT3 pathways.	STAT3
33544565	10.1097/PAS.0000000000001658	2021	Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II.	STAT3
33550887	10.1080/10428194.2021.1881511	2021	PD-L1 expression in peripheral T-cell lymphomas is not related to either <i>PD-L1</i> gene amplification or rearrangements.	STAT3
33632668	10.1016/j.clml.2020.12.012	2021	A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination With Tremelimumab or Danvatirsen in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.	STAT3
33641239	10.1111/gbb.12729	2021	Binge-like ethanol drinking activates anaplastic lymphoma kinase signaling and increases the expression of STAT3 target genes in the mouse hippocampus and prefrontal cortex.	STAT3
33649847	10.3892/mmr.2021.11947	2021	Chidamide induces apoptosis in DLBCL cells by suppressing the HDACs/STAT3/Bcl‑2 pathway.	STAT3
33651821	10.1371/journal.pone.0247394	2021	IL-6 promotes MYC-induced B cell lymphomagenesis independent of STAT3.	STAT3
33660353	10.1111/tbj.14205	2021	Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway.	STAT3
33664848	10.7150/thno.54343	2021	The immune contexture of primary central nervous system diffuse large B cell lymphoma associates with patient survival and specific cell signaling.	STAT3
33667957	10.1016/j.archoralbio.2021.105085	2021	Gold nanoparticles conjugated with programmed death-ligand 1 antibodies induce apoptosis of SCC-25 oral squamous cell carcinoma cells via programmed death-ligand 1/signal transducer and transcription 3 pathway.	STAT3
33687890	10.2174/1871529X21666210308111546	2021	Preclinical Studies of PROTACs in Hematological Malignancies.	STAT3
33692440	10.1038/s41374-021-00581-x	2021	Feline low-grade intestinal T cell lymphoma: a unique natural model of human indolent T cell lymphoproliferative disorder of the gastrointestinal tract.	STAT3
33705488	10.1371/journal.pone.0248298	2021	Ruxolitinib with resminostat exert synergistic antitumor effects in Cutaneous T-cell Lymphoma.	STAT3
33714841	10.1016/j.coi.2021.02.008	2021	Human MALT1 deficiency and predisposition to infections.	STAT3
33715582	10.1080/10428194.2021.1894642	2021	miR-145-5p exerts anti-tumor effects in diffuse large B-cell lymphoma by regulating S1PR1/STAT3/AKT pathway.	STAT3
33728771	10.1111/cas.14885	2021	The ALK inhibitors, alectinib and ceritinib, induce ALK-independent and STAT3-dependent glioblastoma cell death.	STAT3
33757561	10.1186/s13104-021-05521-y	2021	HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL).	STAT3
33758275	10.1038/s41598-021-86021-8	2021	Efficacy of combination treatment using YHO-1701, an orally active STAT3 inhibitor, with molecular-targeted agents on cancer cell lines.	STAT3
33761896	10.1186/s12885-021-07905-6	2021	EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells.	STAT3
33771682	10.1016/j.etap.2021.103639	2021	Interleukin-6 reverses Adriamycin resistance in nasal NK/T-cell lymphoma via downregulation of ABCC4 and inactivation of the JAK2/STAT3/NF-κB/P65 pathway.	STAT3
33777671	10.1016/j.apsb.2020.10.022	2021	Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment.	STAT3
33799222	10.1016/j.phymed.2021.153545	2021	Cucurbitacin B induces apoptosis of primary effusion lymphoma via disruption of cytoskeletal organization.	STAT3
33828027	10.1248/bpb.b21-00163	2021	MicroRNA-221 Upregulates the Expression of P-gp and Bcl-2 by Activating the Stat3 Pathway to Promote Doxorubicin Resistance in Osteosarcoma Cells.	STAT3
33841008	10.1016/j.jgr.2019.12.007	2021	Anti-tumor activities of <i>Panax quinquefolius</i> saponins and potential biomarkers in prostate cancer.	STAT3
33876201	10.1182/blood.2020009404	2021	Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCL.	STAT3
33883905	10.2147/OTT.S292388	2021	Calycosin Induces Gastric Cancer Cell Apoptosis via the ROS-Mediated MAPK/STAT3/NF-κB Pathway.	STAT3
33889291	10.4239/wjd.v12.i4.466	2021	Elevated retinol binding protein 4 levels are associated with atherosclerosis in diabetic rats <i>via</i> JAK2/STAT3 signaling pathway.	STAT3
33899787	10.1097/PAS.0000000000001691	2021	The Positivity of Phosphorylated STAT3 Is a Novel Marker for Favorable Prognosis in Germinal Center B-Cell Type of Diffuse Large B-Cell Lymphoma.	STAT3
33901030	10.1097/PAI.0000000000000936	2021	ALK-Negative Anaplastic Large Cell Lymphoma (ALCL): Prognostic Implications of Molecular Subtyping and JAK-STAT Pathway.	STAT3
33928032	10.3389/fonc.2021.643620	2021	Cytoskeleton Dynamics in Peripheral T Cell Lymphomas: An Intricate Network Sustaining Lymphomagenesis.	STAT3
33932101	10.1002/1878-0261.12969	2021	Tumour-derived substrate-adherent cells promote neuroblastoma survival through secreted trophic factors.	STAT3
33951889	10.3324/haematol.2020.271957	2021	MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma.	STAT3
33954056	10.7717/peerj.11264	2021	Melatonin ameliorates myocardial injury by reducing apoptosis and autophagy of cardiomyocytes in a rat cardiopulmonary bypass model.	STAT3
33987937	10.1002/iub.2503	2021	Lovastatin reduces PEL cell survival by phosphorylating ERK1/2 that blocks the autophagic flux and engages a cross-talk with p53 to activate p21.	STAT3
34039950	10.1038/s41408-021-00493-5	2021	Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing.	STAT3
34090412	10.1186/s12890-021-01553-z	2021	EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation.	STAT3
34128135	10.1007/s10689-021-00266-w	2021	The paradigm of hematological malignant versus non-malignant manifestations, driven by primary immunodeficiencies: a complex interplay.	STAT3
34151703	10.1080/10428194.2021.1941929	2021	Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK + LBCL): a systematic review of clinicopathological features and management.	STAT3
34208159	10.3390/ijms22126291	2021	Functional Analysis of the Promoter Regions of Two Apoptosis-Related Genes (<i>Bcl-2</i> and <i>Cycs</i>) and Their Regulation by Zn in Yellow Catfish.	STAT3
34242968	10.1016/j.esmoop.2021.100172	2021	Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma.	STAT3
34244887	10.1007/s11033-021-06528-1	2021	Atiprimod triggered apoptotic cell death via acting on PERK/eIF2α/ATF4/CHOP and STAT3/NF-ΚB axis in MDA-MB-231 and MDA-MB-468 breast cancer cells.	STAT3
34258755	10.1111/bjh.17639	2021	Characteristics of genetic alterations of peripheral T-cell lymphoma in childhood including identification of novel fusion genes: the Japan Children's Cancer Group (JCCG).	STAT3
34272731	10.1111/bjh.17708	2021	EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features.	STAT3
34282785	10.3390/cancers13133367	2021	Potent Anticancer Effects of Epidithiodiketopiperazine NT1721 in Cutaneous T Cell Lymphoma.	STAT3
34295778	10.21037/tp-21-39	2021	Effect of SOCS3 on apoptosis of human trophoblasts via adjustment of the JAK2/STAT3 signaling pathway in preterm birth.	STAT3
34297745	10.1371/journal.ppat.1009764	2021	Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination.	STAT3
34303663	10.1016/j.ejphar.2021.174373	2021	The antipsychotic drug pimozide is effective against human T-cell leukemia virus type 1-infected T cells.	STAT3
34322285		2021	The non-leukemic T cell large granular lymphocytic leukemia variant with marked splenomegaly and neutropenia in the setting of rheumatoid arthritis - Felty syndrome and hepatosplenic T cell lymphoma mask.	STAT3
34349069	10.11406/rinketsu.62.835	2021	[The road to treating chronic active Epstein-Barr viral infection].	STAT3
34355652	10.1080/10428194.2021.1961231	2021	Trametinib enhances ATRA-induced differentiation in AML cells.	STAT3
34376672	10.1038/s41467-021-25101-9	2021	Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma.	STAT3
34384156	10.3760/cma.j.issn.0253-2727.2021.06.009	2021	[Clinical characteristics of T-cell large granular lymphoblastic leukemia with STAT3 gene mutation].	STAT3
34395444	10.3389/fcell.2021.714298	2021	Functional and Clinical Characteristics of Cell Adhesion Molecule CADM1 in Cancer.	STAT3
34440920	10.3390/cells10082151	2021	Inhibition of STAT3/PD-L1 and Activation of miR193a-5p Are Critically Involved in Apoptotic Effect of Compound K in Prostate Cancer Cells.	STAT3
34447369	10.3389/fimmu.2021.671755	2021	Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management.	STAT3
34455369	10.1016/j.bbrc.2021.08.051	2021	Involvement of EZH2 inhibition in lenalidomide and pomalidomide-mediated growth suppression in HTLV-1-infected cells.	STAT3
34466072	10.1016/j.sjbs.2021.07.072	2021	Chemical composition and pharmacological bio-efficacy of <i>Parrotiopsis jacquemontiana</i> (Decne) Rehder for anticancer activity.	STAT3
34489160	10.1016/j.jjcc.2021.08.018	2021	LncRNA MIAT knockdown alleviates oxygen-glucose deprivation‑induced cardiomyocyte injury by regulating JAK2/STAT3 pathway via miR-181a-5p.	STAT3
34504101	10.1038/s41467-021-25622-3	2021	TNK1 is a ubiquitin-binding and 14-3-3-regulated kinase that can be targeted to block tumor growth.	STAT3
34508914	10.1016/j.bj.2021.08.012	2021	We refuse to die - T cells causing havoc.	STAT3
34535012	10.1182/bloodadvances.2021004562	2021	Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations.	STAT3
34563576	10.1016/j.ijbiomac.2021.09.095	2021	The crystal structure of the domain-swapped dimer of onconase highlights some catalytic and antitumor activity features of the enzyme.	STAT3
34572418	10.3390/biomedicines9091233	2021	Overexpression of Neuron-Derived Orphan Receptor 1 (NOR-1) Rescues Cardiomyocytes from Cell Death and Improves Viability after Doxorubicin Induced Stress.	STAT3
34572893	10.3390/cancers13184667	2021	ALK-Negative Anaplastic Large Cell Lymphoma: Current Concepts and Molecular Pathogenesis of a Heterogeneous Group of Large T-Cell Lymphomas.	STAT3
34588425	10.1038/s41420-021-00655-1	2021	The JAK2 inhibitor TG101209 exhibits anti-tumor and chemotherapeutic sensitizing effects on Burkitt lymphoma cells by inhibiting the JAK2/STAT3/c-MYB signaling axis.	STAT3
34628002	10.1016/j.cellsig.2021.110167	2021	Artesunate induces apoptosis, autophagy and ferroptosis in diffuse large B cell lymphoma cells by impairing STAT3 signaling.	STAT3
34638962	10.3390/ijms221910623	2021	Acetaminophen-Induced Liver Injury Exposes Murine IL-22 as Sex-Related Gene Product.	STAT3
34654425	10.1186/s12943-021-01437-0	2021	DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes.	STAT3
34680385	10.3390/cancers13205238	2021	A Recurrent <i>STAT5B<sup>N642H</sup></i> Driver Mutation in Feline Alimentary T Cell Lymphoma.	STAT3
34710755	10.1016/j.phymed.2021.153802	2021	Myricetin exhibit selective anti-lymphoma activity by targeting BTK and is effective via oral administration in vivo.	STAT3
34736477	10.1186/s12935-021-02296-x	2021	CircADARB1 serves as a new biomarker in natural killer T-cell lymphoma and a potential regulator of p-Stat3.	STAT3
34837676	10.22074/cellj.2021.7302	2021	AntagomiR-19a Induced Better Responsiveness to Bortezomib in Myeloma Cell Lines.	STAT3
34853180	10.1136/jitc-2021-003176	2021	Switch receptor T3/28 improves long-term persistence and antitumor efficacy of CAR-T cells.	STAT3
34858727	10.1080/2162402X.2021.2003533	2021	Tumor cell-derived IL-10 promotes cell-autonomous growth and immune escape in diffuse large B-cell lymphoma.	STAT3
34900688	10.3389/fonc.2021.738085	2021	Combination of Auranofin and ICG-001 Suppress the Proliferation and Metastasis of Colon Cancer.	STAT3
34906296		2021	[Naringin inhibits the proliferation and invasion of Eca109 esophageal cancer cells and promotes its apoptosis by blocking JAK/STAT signal pathway].	STAT3
35116524	10.21037/tcr-20-3018	2021	Procyanidins mediates antineoplastic effects against non-small cell lung cancer via the JAK2/STAT3 pathway.	STAT3
28609201	10.1080/21541248.2017.1341365	2020	Opposite functions of STAT3 and Smad3 in regulating Tiam1 expression in Th17 cells.	STAT3
31049933	10.1111/bjd.18098	2020	Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways.	STAT3
31383967	10.1038/s41379-019-0336-3	2020	PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma.	STAT3
31390055	10.1111/bjd.18353	2020	Deregulated signalling and inflammation in cutaneous T-cell lymphoma.	STAT3
31441360	10.1080/10428194.2019.1654096	2020	Identification of microRNAs modulated by DNA hypomethylating drugs in extranodal NK/T-cell lymphoma.	STAT3
31610171	10.1016/j.ajpath.2019.09.005	2020	Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.	STAT3
31623480	10.1080/10428194.2019.1678154	2020	STAT3, tumor microenvironment, and microvessel density in diffuse large B cell lymphomas.	STAT3
31663116	10.1002/jcp.29338	2020	miR-22-3p enhances the intrinsic regenerative abilities of primary sensory neurons via the CBL/p-EGFR/p-STAT3/GAP43/p-GAP43 axis.	STAT3
31736340	10.1152/ajpgi.00130.2019	2020	Antitumor activity and combined inhibitory effect of ceritinib with gemcitabine in pancreatic cancer.	STAT3
31773249	10.1007/s00428-019-02704-8	2020	Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas.	STAT3
31774495	10.1182/blood.2019001904	2020	Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.	STAT3
31778838	10.1016/j.wneu.2019.11.100	2020	STAT3 Activation Is Associated with Interleukin-10 Expression and Survival in Primary Central Nervous System Lymphoma.	STAT3
31801855	10.1128/JVI.01384-19	2020	Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3.	STAT3
31804622	10.1038/s41388-019-1136-4	2020	The mechanism of cancer drug addiction in ALK-positive T-Cell lymphoma.	STAT3
31822801	10.1038/s41379-019-0415-5	2020	Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America.	STAT3
31836854	10.1038/s41375-019-0678-3	2020	Targetability of STAT3-JAK2 fusions: implications for T-cell lymphoproliferative disorders of the gastrointestinal tract.	STAT3
31845004	10.1007/s00418-019-01834-z	2020	RNAscope dual ISH-IHC technology to study angiogenesis in diffuse large B-cell lymphomas.	STAT3
31889428	10.1002/kjm2.12181	2020	miR-636 represses cell survival by targeting CDK6/Bcl-2 in cervical cancer.	STAT3
31896810	10.1038/s41379-019-0448-9	2020	PD-L1 expression in anaplastic large cell lymphoma.	STAT3
31918398	10.1016/j.bioorg.2019.103542	2020	JAK3 inhibitors based on thieno[3,2-d]pyrimidine scaffold: design, synthesis and bioactivity evaluation for the treatment of B-cell lymphoma.	STAT3
31935288	10.1182/bloodadvances.2019000947	2020	Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas.	STAT3
31956933	10.1007/s10637-020-00896-4	2020	KRCA-0008 suppresses ALK-positive anaplastic large-cell lymphoma growth.	STAT3
31957855	10.26355/eurrev_202001_19939	2020	Losartan promotes myocardial apoptosis after acute myocardial infarction in rats through inhibiting Ang II-induced JAK/STAT pathway.	STAT3
31961925	10.1182/blood.2019001815	2020	Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions.	STAT3
32004387	10.1111/bjh.16435	2020	Evaluation of the PIK3 pathway in peripheral T-cell lymphoma and NK/T-cell lymphoma.	STAT3
32005797	10.1038/s41408-020-0277-6	2020	SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas.	STAT3
32010998	10.1002/hon.2720	2020	Refractory celiac disease type II: An atypical case highlighting limitations of the current classification system.	STAT3
32021103	10.2147/DDDT.S228610	2020	Curcumin Combined with Thalidomide Reduces Expression of <i>STAT3</i> and <i>Bcl-xL</i>, Leading to Apoptosis in Acute Myeloid Leukemia Cell Lines.	STAT3
32044149	10.1016/j.imbio.2020.151907	2020	Natural Killer cell transcriptome during primary EBV infection and EBV associated Hodgkin Lymphoma in children-A preliminary observation.	STAT3
32110041	10.2147/OTT.S209312	2020	Embelin Promotes Oncolytic Vaccinia Virus-Mediated Antitumor Immunity Through Disruption of IL-6/STAT3 Signaling in Lymphoma.	STAT3
32120334	10.1016/j.tranon.2020.100744	2020	Inflammatory Infiltrate and Angiogenesis in Mantle Cell Lymphoma.	STAT3
32123306	10.1038/s41375-020-0754-8	2020	The novel lncRNA BlackMamba controls the neoplastic phenotype of ALK<sup>-</sup> anaplastic large cell lymphoma by regulating the DNA helicase HELLS.	STAT3
32141561	10.26355/eurrev_202002_20370	2020	MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma.	STAT3
32183146	10.3390/molecules25061320	2020	Evodiamine Mitigates Cellular Growth and Promotes Apoptosis by Targeting the c-Met Pathway in Prostate Cancer Cells.	STAT3
32185560	10.1007/s11894-020-0756-8	2020	Refractory Celiac Disease.	STAT3
32188095	10.3390/cancers12030702	2020	<i>STAT3</i> Mutation Is Associated with STAT3 Activation in CD30<sup>+</sup> ALK<sup>-</sup> ALCL.	STAT3
32194752	10.3892/ol.2020.11315	2020	Inhibiting the Src/STAT3 signaling pathway contributes to the anti-melanoma mechanisms of dioscin.	STAT3
32196559	10.1182/bloodadvances.2019001429	2020	Proteomic profiling of HTLV-1 carriers and ATL patients reveals sTNFR2 as a novel diagnostic biomarker for acute ATL.	STAT3
32203093	10.1038/s41379-020-0522-3	2020	Reply to ""PD-L1 expression in anaplastic large cell lymphoma"".	STAT3
32271188	10.1097/PAS.0000000000001470	2020	Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders: A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous Lymphoma Study Group.	STAT3
32296013	10.1038/s41392-020-0123-0	2020	A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2/STAT3 pathway.	STAT3
32312912	10.26508/lsa.201900601	2020	Oncogenic <i>ALK</i> <sup><i>F1174L</i></sup> drives tumorigenesis in cutaneous squamous cell carcinoma.	STAT3
32352029	10.1038/s41523-020-0157-z	2020	BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progression.	STAT3
32391356	10.3389/fcell.2020.00262	2020	A Dual TLR7/TLR9 Inhibitor HJ901 Inhibits ABC-DLBCL Expressing the MyD88 L265P Mutation.	STAT3
32394008	10.1007/s10495-020-01607-3	2020	Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination.	STAT3
32420596	10.1042/CS20200032	2020	Deregulation of miRNAs-cMYC circuits is a key event in refractory celiac disease type-2 lymphomagenesis.	STAT3
32463472	10.1042/BSR20190318	2020	Effect of hnRNPA2/B1 on the proliferation and apoptosis of glioma U251 cells via the regulation of AKT and STAT3 pathways.	STAT3
32466622	10.3390/vaccines8020250	2020	Cloning and Expression of the Tibetan Pig Interleukin-23 Gene and Its Promotion of Immunity of Pigs to PCV2 Vaccine.	STAT3
32471947	10.1073/pnas.1922884117	2020	HTLV-1 induces T cell malignancy and inflammation by viral antisense factor-mediated modulation of the cytokine signaling.	STAT3
32484926	10.1002/cncr.32985	2020	Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibition.	STAT3
32554052	10.1016/j.imlet.2020.06.008	2020	Eomesodermin promotes interaction of RelA and NFATc2 with the Ifng promoter and multiple conserved noncoding sequences across the Ifng locus in mouse lymphoma BW5147 cells.	STAT3
32565964	10.3892/ol.2020.11552	2020	Comprehensive characterization of driver genes in diffuse large B cell lymphoma.	STAT3
32573700	10.1182/blood.2019003793	2020	IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma.	STAT3
32637355	10.3389/fonc.2020.00898	2020	Genomics of Peripheral T-Cell Lymphoma and Its Implications for Personalized Medicine.	STAT3
32641029	10.1186/s12906-020-03006-2	2020	Matrine inhibits the growth of natural killer/T-cell lymphoma cells by modulating CaMKIIγ-c-Myc signaling pathway.	STAT3
32643174	10.1111/ijd.15036	2020	Mapping signal transducer and activator of transcription (STAT) activity in different stages of mycosis fungoides and Sezary syndrome.	STAT3
32658867	10.18632/aging.103490	2020	CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ/ Stat3 axis.	STAT3
32668392	10.1016/j.omtn.2020.06.016	2020	The Role and Underlying Mechanism of Exosomal CA1 in Chemotherapy Resistance in Diffuse Large B Cell Lymphoma.	STAT3
32671511	10.1007/s10528-020-09982-x	2020	TIAM1 Upregulation Confers NVP-BEZ235 Resistance to Breast Cancer Cells Through FGFR/STAT3 Pathway.	STAT3
32682634	10.1016/j.jdermsci.2020.06.013	2020	Hydroa vacciniforme-like lymphoproliferative disorder: A study of clinicopathology and whole-exome sequencing in Chinese patients.	STAT3
32704112	10.1038/s41598-020-69227-0	2020	IL-21 Stimulates the expression and activation of cell cycle regulators and promotes cell proliferation in EBV-positive diffuse large B cell lymphoma.	STAT3
32708974	10.3390/genes11070816	2020	BCL2L15 Depletion Inhibits Endometrial Receptivity via the STAT1 Signaling Pathway.	STAT3
32714471	10.1016/j.curtheres.2020.100589	2020	Cell Death by Gallotannin Is Associated with Inhibition of the JAK/STAT Pathway in Human Colon Cancer Cells.	STAT3
32735617	10.1371/journal.ppat.1008701	2020	Interleukin 16 contributes to gammaherpesvirus pathogenesis by inhibiting viral reactivation.	STAT3
32744682	10.26355/eurrev_202007_22251	2020	MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway.	STAT3
32779615	10.3960/jslrt.20019	2020	Clinical application of genomic aberrations in adult T-cell leukemia/lymphoma.	STAT3
32798587	10.1016/j.canlet.2020.07.032	2020	Napabucasin, a novel inhibitor of STAT3, inhibits growth and synergises with doxorubicin in diffuse large B-cell lymphoma.	STAT3
32850389	10.3389/fonc.2020.01276	2020	Indolent T-Cell Lymphoproliferative Disease of the GI Tract: Insights for Better Diagnosis, Prognosis, and Appropriate Therapy.	STAT3
32858764	10.1111/jcmm.15774	2020	IKKε and TBK1 in diffuse large B-cell lymphoma: A possible mechanism of action of an IKKε/TBK1 inhibitor to repress NF-κB and IL-10 signalling.	STAT3
32859630	10.21873/cgp.20208	2020	Combination of ERK2 and STAT3 Inhibitors Promotes Anticancer Effects on Acute Lymphoblastic Leukemia Cells.	STAT3
32865519	10.1172/JCI133283	2020	Beclin 2 negatively regulates innate immune signaling and tumor development.	STAT3
32865793	10.1007/978-1-0716-0771-8_15	2020	Targeted Gene Silencing in Malignant Hematolymphoid Cells Using GapmeR.	STAT3
32866816	10.1016/j.jns.2020.117102	2020	Preconditioning with INC280 and LDK378 drugs sensitizes MGMT-unmethylated glioblastoma to temozolomide: Pre-clinical assessment.	STAT3
32876369	10.1111/cas.14638	2020	Synergistic effect of ibrutinib and CD19 CAR-T cells on Raji cells in vivo and in vitro.	STAT3
32922661	10.18632/oncotarget.27683	2020	The NKL-code for innate lymphoid cells reveals deregulated expression of NKL homeobox genes HHEX and HLX in anaplastic large cell lymphoma (ALCL).	STAT3
32966974	10.1159/000500713	2020	HDAC3 Silencing Enhances Acute B Lymphoblastic Leukaemia Cells Sensitivity to MG-132 by Inhibiting the JAK/Signal Transducer and Activator of Transcription 3 Signaling Pathway.	STAT3
32992412	10.3760/cma.j.cn112151-20200205-00066	2020	[Expression of pSTAT3 and PD-L1 in extranodal NK/T cell lymphoma and its clinical significance].	STAT3
33002095	10.1371/journal.ppat.1008849	2020	STAT3 imparts BRCAness by impairing homologous recombination repair in Epstein-Barr virus-transformed B lymphocytes.	STAT3
33102814	10.1016/j.bbrep.2020.100832	2020	Cucurbitacin E and I target the JAK/STAT pathway and induce apoptosis in Sézary cells.	STAT3
33113625	10.3760/cma.j.cn112152-20200220-00107	2020	[Silencing PBX1 expression induces apoptosis and ROS production of lung cancer cells].	STAT3
33123290	10.7150/jca.47816	2020	Plasma soluble PD-L1 and STAT3 predict the prognosis in diffuse large B cell lymphoma patients.	STAT3
33141118	10.1172/JCI134990	2020	ALK-transformed mature T lymphocytes restore early thymus progenitor features.	STAT3
33212804	10.3390/ph13110397	2020	Small-Dose Sunitinib Modulates p53, Bcl-2, STAT3, and ERK1/2 Pathways and Protects against Adenine-Induced Nephrotoxicity.	STAT3
33225311	10.1158/2643-3230.BCD-20-0051	2020	Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK-STAT pathway.	STAT3
33228022	10.3390/cancers12113435	2020	Carcinoma-Associated Fibroblasts Promote Growth of Sox2-Expressing Breast Cancer Cells.	STAT3
33260630	10.3390/genes11121434	2020	TYK2 Variants in B-Acute Lymphoblastic Leukaemia.	STAT3
33318172	10.1073/pnas.2013194117	2020	HIV proviral DNA integration can drive T cell growth ex vivo.	STAT3
33322712	10.3390/molecules25245881	2020	The Anti-Cancer Effect of Linusorb B3 from Flaxseed Oil through the Promotion of Apoptosis, Inhibition of Actin Polymerization, and Suppression of Src Activity in Glioblastoma Cells.	STAT3
33323828	10.1097/CM9.0000000000001294	2020	R-CHOP resistance in diffuse large B-cell lymphoma: biological and molecular mechanisms.	STAT3
33331925	10.1182/blood.2020005372	2020	Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.	STAT3
33333886	10.3390/cells9122692	2020	Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma.	STAT3
33376237	10.1038/s41392-020-00331-3	2020	Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma.	STAT3
34661140	10.1158/2643-3249.BCD-20-0075	2020	The Genomic Landscape of HIV-Associated Plasmablastic Lymphoma.	STAT3
35117335	10.21037/tcr-20-2151	2020	Primary pulmonary extranodal NK/T-cell lymphoma: a case report and literature review.	STAT3
29792338	10.1177/0960327118777869	2019	Molecular mechanism for the influence of gender dimorphism on alcoholic liver injury in mice.	STAT3
29911923	10.1080/10428194.2018.1461861	2019	MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia.	STAT3
30030006	10.1016/j.jaci.2018.06.036	2019	Human T<sub>H</sub>9 differentiation is dependent on signal transducer and activator of transcription (STAT) 3 to restrain STAT1-mediated inhibition.	STAT3
30131584	10.1038/s41375-018-0239-1	2019	Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma.	STAT3
30198914	10.1097/CAD.0000000000000692	2019	Effects of 9-cis-retinoic acid on the proliferation and apoptosis of cutaneous T-cell lymphoma cells.	STAT3
30206415	10.1038/s41379-018-0130-7	2019	Transcriptional analysis distinguishes breast implant-associated anaplastic large cell lymphoma from other peripheral T-cell lymphomas.	STAT3
30218753	10.1016/j.humpath.2018.08.025	2019	Aberrant differential expression of EZH2 and H3K27me3 in extranodal NK/T-cell lymphoma, nasal type, is associated with disease progression and prognosis.	STAT3
30299211	10.1080/15384047.2018.1504721	2019	MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1.	STAT3
30348636	10.1158/1078-0432.CCR-18-1153	2019	Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma.	STAT3
30365149	10.3892/or.2018.6798	2019	I157172, a novel inhibitor of cystathionine γ-lyase, inhibits growth and migration of breast cancer cells via SIRT1-mediated deacetylation of STAT3.	STAT3
30370578	10.1002/jcp.27398	2019	microRNA-874 inhibition targeting STAT3 protects the heart from ischemia-reperfusion injury by attenuating cardiomyocyte apoptosis in a mouse model.	STAT3
30371509	10.1097/PAS.0000000000001180	2019	Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas.	STAT3
30381301	10.3324/haematol.2018.201590	2019	TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation <i>via</i> NF-κB mediated signaling in B-cells.	STAT3
30387321	10.1111/jcmm.13945	2019	Dynein axonemal intermediate chain 2 plays a role in gametogenesis by activation of Stat3.	STAT3
30395862	10.1016/j.athoracsur.2018.09.031	2019	Pretreatment With Diazoxide Attenuates Spinal Cord Ischemia-Reperfusion Injury Through Signaling Transducer and Activator of Transcription 3 Pathway.	STAT3
30431687	10.1002/jbt.22243	2019	Evaluation of the renoprotective effect of nano turmeric against toxic dose of copper sulfate: Role of vascular cell adhesion molecule-1, kidney injury molecule-1, and signal transducer and activator of transcription 3 protein expressions.	STAT3
30446590	10.1158/1078-0432.CCR-18-1226	2019	Neutrophil Extracellular Traps Induced by IL8 Promote Diffuse Large B-cell Lymphoma Progression via the TLR9 Signaling.	STAT3
30450688	10.1111/1346-8138.14702	2019	Papuloerythroderma-like cutaneous involvement of a CD62L<sup>-</sup> subclone of T-cell prolymphocytic leukemia.	STAT3
30510251	10.1038/s41591-018-0262-9	2019	Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma.	STAT3
30529073	10.1016/j.neo.2018.11.006	2019	Preclinical Studies Support Combined Inhibition of BET Family Proteins and Histone Deacetylases as Epigenetic Therapy for Cutaneous T-Cell Lymphoma.	STAT3
30530749	10.1182/blood-2018-05-851667	2019	Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma.	STAT3
30535477	10.3892/ijmm.2018.4012	2019	Cryptotanshinone induces reactive oxygen species‑mediated apoptosis in human rheumatoid arthritis fibroblast‑like synoviocytes.	STAT3
30567732	10.4049/jimmunol.1800876	2019	BCL6-Mediated Silencing of PD-1 Ligands in Germinal Center B Cells Maintains Follicular T Cell Population.	STAT3
30623224	10.1007/s00347-018-0840-8	2019	[New molecular pathological strategies for malignant iris tumors].	STAT3
30631148	10.1038/s41388-018-0670-9	2019	Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.	STAT3
30639963	10.1016/j.tranon.2018.12.008	2019	STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma.	STAT3
30658101	10.1016/j.lfs.2019.01.022	2019	PIM inhibitor SMI-4a induces cell apoptosis in B-cell acute lymphocytic leukemia cells via the HO-1-mediated JAK2/STAT3 pathway.	STAT3
30675310	10.3892/ol.2018.9838	2019	MicroRNA-543 suppresses liver cancer growth and induces apoptosis via the JAK2/STAT3 signaling pathway.	STAT3
30692217	10.1158/0008-5472.CAN-18-0359	2019	The Transcriptional Regulator Sin3A Contributes to the Oncogenic Potential of STAT3.	STAT3
30715169	10.1093/asj/sjy311	2019	Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).	STAT3
30715174	10.1093/asj/sjy250	2019	What Cytokines Can Tell Us About the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).	STAT3
30726736	10.1016/j.celrep.2019.01.034	2019	Bone Marrow Mesenchymal Stromal Cell-Derived Periostin Promotes B-ALL Progression by Modulating CCL2 in Leukemia Cells.	STAT3
30741923	10.1038/s41467-019-08605-3	2019	Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation.	STAT3
30745139	10.1016/j.clml.2018.12.020	2019	Prognostic Significance of Serum Copper in Patients With Cutaneous T-cell Lymphoma.	STAT3
30747218	10.3892/or.2019.6976	2019	Gallic acid has anticancer activity and enhances the anticancer effects of cisplatin in non‑small cell lung cancer A549 cells via the JAK/STAT3 signaling pathway.	STAT3
30755239	10.1186/s13046-019-1081-7	2019	Human bone marrow-derived mesenchymal stem cells promote the growth and drug-resistance of diffuse large B-cell lymphoma by secreting IL-6 and elevating IL-17A levels.	STAT3
30770362	10.1182/bloodadvances.2018020602	2019	PD-L1 and tumor-associated macrophages in de novo DLBCL.	STAT3
30782609	10.1182/blood-2018-09-872549	2019	Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.	STAT3
30787154	10.1128/JVI.02290-18	2019	Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3.	STAT3
30805320	10.3389/fped.2019.00014	2019	Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of Development.	STAT3
30837035	10.3727/096504018X15439207752093	2019	miR-101 Represses T-Cell Acute Lymphoblastic Leukemia by Targeting CXCR7/STAT3 Axis.	STAT3
30864721	10.3892/mmr.2019.10011	2019	CircRNA‑0044073 is upregulated in atherosclerosis and increases the proliferation and invasion of cells by targeting miR‑107.	STAT3
30910759	10.1016/j.jid.2019.03.1130	2019	Contribution of STAT3 and RAD23B in Primary Sézary Cells to Histone Deacetylase Inhibitor FK228 Resistance.	STAT3
30926771	10.1038/s41408-019-0203-y	2019	Inhibition of the STAT3 target SGK1 sensitizes diffuse large B cell lymphoma cells to AKT inhibitors.	STAT3
30935402	10.1186/s13045-019-0716-7	2019	Molecular pathogenic pathways in extranodal NK/T cell lymphoma.	STAT3
30953147	10.1007/s00428-019-02570-4	2019	Systemic, primary cutaneous, and breast implant-associated ALK-negative anaplastic large-cell lymphomas present similar biologic features despite distinct clinical behavior.	STAT3
30962205	10.1182/blood.2018880138	2019	Chronic CD30 signaling in B cells results in lymphomagenesis by driving the expansion of plasmablasts and B1 cells.	STAT3
30972748	10.1002/jcp.28410	2019	microRNA-30a inhibits the liver cell proliferation and promotes cell apoptosis through the JAK/STAT signaling pathway by targeting SOCS-1 in rats with sepsis.	STAT3
30988279	10.1038/s41419-019-1563-8	2019	Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma.	STAT3
31002169	10.26355/eurrev_201904_17586	2019	Effect of IL-6-mediated STAT3 signaling pathway on myocardial apoptosis in mice with dilated cardiomyopathy.	STAT3
31002364	10.3892/or.2019.7112	2019	JAK3/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK/T‑cell lymphoma, nasal type.	STAT3
31032347	10.1155/2019/4860268	2019	Icaritin: A Novel Natural Candidate for Hematological Malignancies Therapy.	STAT3
31038184	10.5114/fn.2019.83827	2019	Ginkgetin aglycone attenuates neuroinflammation and neuronal injury in the rats with ischemic stroke by modulating STAT3/JAK2/SIRT1.	STAT3
31044025	10.4081/oncol.2019.400	2019	Prognostic significance of aberrant CD5 expression in B-cell leukemia.	STAT3
31054507	10.1016/j.biopha.2019.108913	2019	Promoter methylation and expression of SOCS3 affect the clinical outcome of pediatric acute lymphoblastic leukemia by JAK/STAT pathway.	STAT3
31098955	10.1007/s12539-019-00331-0	2019	PD-L1 Expression and Its Regulation in Lung Adenocarcinoma with ALK Translocation.	STAT3
31108175	10.1016/j.fsi.2019.05.034	2019	Ctenopharyngodon Idella STAT3 alleviates autophagy by up-regulating BCL-2 expression.	STAT3
31125630	10.1016/j.humpath.2019.05.007	2019	Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas.	STAT3
31141539	10.1371/journal.pone.0216898	2019	Epstein-Barr virus (EBV) activates NKL homeobox gene HLX in DLBCL.	STAT3
31151983	10.1182/blood.2019001043	2019	A novel model of controlling PD-L1 expression in ALK<sup>+</sup> anaplastic large cell lymphoma revealed by CRISPR screening.	STAT3
31155767	10.1111/jpn.13110	2019	Dietary l-arginine supplementation influences growth performance and B-cell secretion of immunoglobulin in broiler chickens.	STAT3
31213131	10.1080/15384101.2019.1629789	2019	miR-337 suppresses cutaneous T-cell lymphoma via the STAT3 pathway.	STAT3
31237072	10.1111/cas.14114	2019	Phosphorylated STAT3 expression predicts better prognosis in smoldering type of adult T-cell leukemia/lymphoma.	STAT3
31311407	10.1080/15384047.2019.1638670	2019	Somatic mutations in <i>KMT2D</i> and <i>TET2</i> associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disorders.	STAT3
31313387	10.1002/JLB.5RU0519-145R	2019	JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy.	STAT3
31321184	10.1097/GOX.0000000000002188	2019	Synchronous Breast Implant-associated Anaplastic Large Cell Lymphoma and Invasive Carcinoma: Genomic Profiling and Management Implications.	STAT3
31331920	10.1182/blood.2018888107	2019	Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma.	STAT3
31364140	10.26355/eurrev_201907_18456	2019	Effect of propofol on myocardial ischemia/reperfusion injury in rats through JAK/STAT signaling pathway.	STAT3
31364141	10.26355/eurrev_201907_18457	2019	Effects of propofol on myocardial ischemia reperfusion injury through inhibiting the JAK/STAT pathway.	STAT3
31364493	10.1161/JAHA.119.012047	2019	Systems Network Genomic Analysis Reveals Cardioprotective Effect of MURC/Cavin-4 Deletion Against Ischemia/Reperfusion Injury.	STAT3
31390744	10.3390/cancers11081119	2019	NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma.	STAT3
31391340	10.1172/jci.insight.128435	2019	Activated gp130 signaling selectively targets B cell differentiation to induce mature lymphoma and plasmacytoma.	STAT3
31394087	10.1016/j.yexmp.2019.104294	2019	RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment.	STAT3
31404445	10.1007/s12308-019-00354-y	2019	Evaluation of S1PR1, pSTAT3, S1PR2, FOXP1 Expression in Aggressive, Mature B Cell Lymphomas.	STAT3
31503548	10.1172/JCI127721	2019	Myeloid loss of Beclin 1 promotes PD-L1hi precursor B cell lymphoma development.	STAT3
31515941	10.15252/emmm.201910576	2019	The IL-6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B-cell lymphoma.	STAT3
31568628	10.1111/jcmm.14653	2019	Non-lethal proteasome inhibition activates pro-tumorigenic pathways in multiple myeloma cells.	STAT3
31585620	10.1016/j.beha.2019.06.003	2019	Genomics of LGL leukemia and select other rare leukemia/lymphomas.	STAT3
31601188	10.1186/s12885-019-6057-7	2019	Interleukin-6 mediates resistance to PI3K-pathway-targeted therapy in lymphoma.	STAT3
31627175	10.1016/j.pharep.2019.05.021	2019	N-Acetyl cysteine prevents activities of STAT3 inhibitors, Stattic and BP-1-102 independently of its antioxidant properties.	STAT3
31654627	10.1016/j.bcp.2019.113666	2019	Methotrexate significantly induces apoptosis by inhibiting STAT3 activation in NPM-ALK-positive ALCL cells.	STAT3
31684088	10.3390/cancers11111711	2019	STAT3 Dysregulation in Mature T and NK Cell Lymphomas.	STAT3
31693087	10.1042/BSR20182376	2019	Emerging roles of the long non-coding RNA 01296/microRNA-143-3p/MSI2 axis in development of thyroid cancer.	STAT3
31701713	10.12047/j.cjap.5799.2019.066	2019	[Effects of 2-12alkyl-6-methoxycyclohexa-2, 5-diene-1, 4-dione(DMDD)on diffuse large B lymphoma and its mechanism].	STAT3
31715132	10.1016/j.ccell.2019.10.002	2019	A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo.	STAT3
31718693	10.1186/s13046-019-1428-0	2019	Long non-coding RNA RP11-468E2.5 curtails colorectal cancer cell proliferation and stimulates apoptosis via the JAK/STAT signaling pathway by targeting STAT5 and STAT6.	STAT3
31747516	10.1021/acs.jmedchem.9b01530	2019	Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein.	STAT3
31752432	10.3390/ijms20225816	2019	In Vitro Effects of Vaspin on Porcine Granulosa Cell Proliferation, Cell Cycle Progression, and Apoptosis by Activation of GRP78 Receptor and Several Kinase Signaling Pathways Including MAP3/1, AKT, and STAT3.	STAT3
31754348	10.1186/s12935-019-1011-y	2019	Circ_ZNF124 promotes non-small cell lung cancer progression by abolishing miR-337-3p mediated downregulation of JAK2/STAT3 signaling pathway.	STAT3
31772601	10.1155/2019/8128170	2019	Uncovering the Anticancer Mechanism of Compound Sophorae Decoction against Ulcerative Colitis-Related Colorectal Cancer in Mice.	STAT3
31777595	10.7150/jca.30361	2019	The Effects and Mechanisms by which Saikosaponin-D Enhances the Sensitivity of Human Non-small Cell Lung Cancer Cells to Gefitinib.	STAT3
31779213	10.3390/biom9120787	2019	Betulinic Acid Attenuates T-2-Toxin-Induced Testis Oxidative Damage Through Regulation of the JAK2/STAT3 Signaling Pathway in Mice.	STAT3
31783811	10.1186/s12885-019-6381-y	2019	Syndecan-1 suppresses cell growth and migration via blocking JAK1/STAT3 and Ras/Raf/MEK/ERK pathways in human colorectal carcinoma cells.	STAT3
31861597	10.3390/cancers12010019	2019	STAT3 Activation and Oncogenesis in Lymphoma.	STAT3
31901912		2019	pSTAT3 and MYC in Epstein-Barr virus-positive diffuse large B-cell lymphoma.	STAT3
32063711	10.2147/OTT.S222189	2019	Prevalence And Clinical Significance Of Oncogenic <i>CD79B</i> And <i>MYD88</i> Mutations In Primary Testicular Diffuse Large B-Cell Lymphoma: A Retrospective Study In China.	STAT3
32186040		2019	Efficacy of Zhonglun'a-decoction-containing serum on fibroblast-like synoviocyte apoptosis in rats with collagen-induced arthritis via inhibiting Janus kinase/signal transducer and activator of transcription signaling pathway.	STAT3
28633612	10.1080/10428194.2017.1339880	2018	Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL).	STAT3
28665006	10.1002/hon.2455	2018	Partial deletion of the ALK gene in ALK-positive anaplastic large cell lymphoma.	STAT3
28835002	10.4062/biomolther.2017.099	2018	Cripto Enhances Proliferation and Survival of Mesenchymal Stem Cells by Up-Regulating JAK2/STAT3 Pathway in a GRP78-Dependent Manner.	STAT3
28901004	10.1002/eji.201747017	2018	Bcl-3 induced by IL-22 via STAT3 activation acts as a potentiator of psoriasis-related gene expression in epidermal keratinocytes.	STAT3
28905990	10.1002/ijc.31044	2018	The mTOR kinase inhibitor everolimus synergistically enhances the anti-tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS-123 on Mantle cell lymphoma.	STAT3
28940360	10.1111/cei.13054	2018	Lys63-polyubiquitination by the E3 ligase casitas B-lineage lymphoma-b (Cbl-b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus.	STAT3
29084771	10.1182/blood-2017-01-761874	2018	Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma.	STAT3
29097500	10.3324/haematol.2017.179309	2018	A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma.	STAT3
29115552	10.3892/mmr.2017.8008	2018	Effects of daphnetin combined with Bcl2‑siRNA on antiapoptotic genes in synovial fibroblasts of rats with collagen‑induced arthritis.	STAT3
29119628	10.1111/jvim.14860	2018	STAT3 Expression and Activity are Up-Regulated in Diffuse Large B Cell Lymphoma of Dogs.	STAT3
29128259	10.1016/j.jid.2017.10.028	2018	Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma.	STAT3
29164994	10.1080/10428194.2017.1397668	2018	STAT3 inhibition as a therapeutic strategy for leukemia.	STAT3
29207064	10.3892/mmr.2017.8110	2018	Quinalizarin exerts an anti-tumour effect on lung cancer A549 cells by modulating the Akt, MAPK, STAT3 and p53 signalling pathways.	STAT3
29258893	10.1016/j.jid.2017.12.010	2018	LMO4 Is a Disease-Provocative Transcription Coregulator Activated by IL-23 in Psoriatic Keratinocytes.	STAT3
29286137	10.3892/mmr.2017.8348	2018	MicroRNA-124a inhibits cell proliferation and migration in liver cancer by regulating interleukin-11.	STAT3
29295936	10.1073/pnas.1715118115	2018	Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma.	STAT3
29304536	10.1160/TH17-04-0275	2018	Defibrotide Stimulates Angiogenesis and Protects Endothelial Cells from Calcineurin Inhibitor-Induced Apoptosis via Upregulation of AKT/Bcl-xL.	STAT3
29337025	10.1016/j.humpath.2018.01.005	2018	Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors.	STAT3
29346274	10.3390/cancers10010021	2018	IRF4 Mediates the Oncogenic Effects of STAT3 in Anaplastic Large Cell Lymphomas.	STAT3
29353075	10.1016/j.exphem.2018.01.003	2018	BTLA marks a less cytotoxic T-cell subset in diffuse large B-cell lymphoma with high expression of checkpoints.	STAT3
29393473	10.3892/mmr.2018.8543	2018	Protective effects of N(2)‑L‑alanyl‑L‑glutamine mediated by the JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion.	STAT3
29399062	10.3892/etm.2017.5414	2018	The effect of hydroxy safflower yellow A on coronary heart disease through Bcl-2/Bax and PPAR-γ.	STAT3
29399699	10.3892/or.2018.6220	2018	The role of aldehyde dehydrogenase 1A1 in B-cell non-Hodgkin's lymphoma.	STAT3
29433938	10.1016/j.ymthe.2018.01.007	2018	B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors.	STAT3
29434770	10.3892/etm.2017.5600	2018	MicroRNA-519a inhibits the proliferation and promotes the apoptosis of ovarian cancer cells through targeting signal transducer and activator of transcription 3.	STAT3
29434895	10.3892/ol.2017.7502	2018	Dihydroartemisinin increases apoptosis of colon cancer cells through targeting Janus kinase 2/signal transducer and activator of transcription 3 signaling.	STAT3
29434967	10.3892/ol.2017.7593	2018	Celastrol suppresses the proliferation of lung adenocarcinoma cells by regulating microRNA-24 and microRNA-181b.	STAT3
29444468	10.1016/j.ejphar.2018.02.012	2018	A major component of vitamin E, α-tocopherol inhibits the anti-tumor activity of crizotinib against cells transformed by EML4-ALK.	STAT3
29463696	10.1073/pnas.1713889115	2018	Genetic rescue of lineage-balanced blood cell production reveals a crucial role for STAT3 antiinflammatory activity in hematopoiesis.	STAT3
29464048	10.18632/oncotarget.23192	2018	Src is the primary target of aripiprazole, an atypical antipsychotic drug, in its anti-tumor action.	STAT3
29475733	10.1016/j.ymthe.2018.02.006	2018	Decoy-Based, Targeted Inhibition of STAT3: A New Step forward for B Cell Lymphoma Immunotherapy.	STAT3
29477912	10.1016/j.biopha.2018.02.019	2018	Bavachin induces the apoptosis of multiple myeloma cell lines by inhibiting the activation of nuclear factor kappa B and signal transducer and activator of transcription 3.	STAT3
29490645	10.1186/s12967-018-1421-y	2018	Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemia.	STAT3
29496539	10.1016/j.canlet.2018.02.036	2018	Sabutoclax, pan-active BCL-2 protein family antagonist, overcomes drug resistance and eliminates cancer stem cells in breast cancer.	STAT3
29511132	10.1634/theoncologist.2017-0325	2018	A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers.	STAT3
29531812	10.1038/s41420-017-0012-7	2018	Modulation of nuclear factor-kappa B activation by the endoplasmic reticulum stress sensor PERK to mediate estrogen-induced apoptosis in breast cancer cells.	STAT3
29541181	10.3892/ol.2018.7830	2018	Effects of purified <i>Omphalia lapidescens</i> protein on metastasis, cell cycle, apoptosis and the JAK-STAT signaling pathway in SGC-7901 human gastric cells.	STAT3
29581848	10.18632/oncotarget.24512	2018	Aberrant expression of NKL homeobox gene HLX in Hodgkin lymphoma.	STAT3
29595984	10.1021/acs.molpharmaceut.8b00059	2018	Exosomes from Irradiated Nonsmall Cell Lung Cancer Cells Reduced Sensitivity of Recipient Cells to Anaplastic Lymphoma Kinase Inhibitors.	STAT3
29619509	10.1007/s00262-018-2156-6	2018	Interferon-α2b-induced STAT3 suppression in myeloid-derived suppressor cells in mycosis fungoides.	STAT3
29637270	10.1007/s00428-018-2352-y	2018	Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma.	STAT3
29641255	10.1089/cbr.2017.2386	2018	MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway.	STAT3
29650799	10.1182/blood-2017-11-814913	2018	Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma.	STAT3
29666362	10.1038/s41467-018-03803-x	2018	Cooperative STAT/NF-κB signaling regulates lymphoma metabolic reprogramming and aberrant GOT2 expression.	STAT3
29674644	10.1038/s41467-018-03987-2	2018	Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.	STAT3
29681389	10.1016/j.jid.2017.12.022	2018	A Microbiota-Dependent, STAT3-Driven Mouse Model of Cutaneous T-Cell Lymphoma.	STAT3
29689246	10.1016/j.humpath.2018.04.007	2018	IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis.	STAT3
29695237	10.1186/s12885-018-4266-0	2018	Amphotericin B suppresses M2 phenotypes and B7-H1 expression in macrophages to prevent Raji cell proliferation.	STAT3
29702481	10.2478/acph-2018-0013	2018	Paeoniflorin inhibits the growth of bladder carcinoma via deactivation of STAT3.	STAT3
29740433	10.3389/fimmu.2018.00787	2018	SYK Inhibition Induces Apoptosis in Germinal Center-Like B Cells by Modulating the Antiapoptotic Protein Myeloid Cell Leukemia-1, Affecting B-Cell Activation and Antibody Production.	STAT3
29750888	10.33549/physiolres.933738	2018	Adiponectin enhances biological functions of vascular endothelial progenitor cells through the mTOR-STAT3 signaling pathway.	STAT3
29752696	10.1007/s11655-018-2563-8	2018	Total Saponins of Rubus Parvifolius L. Exhibited Anti-Leukemia Effect in vivo through STAT3 and eIF4E Signaling Pathways.	STAT3
29794468	10.1159/000490019	2018	Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma.	STAT3
29805643	10.3892/ol.2018.8522	2018	Chrysin induces cell growth arrest, apoptosis, and ER stress and inhibits the activation of STAT3 through the generation of ROS in bladder cancer cells.	STAT3
29857068	10.1016/j.jid.2018.04.038	2018	Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type.	STAT3
29898964	10.4049/jimmunol.1800400	2018	Early Generated B-1-Derived B Cells Have the Capacity To Progress To Become Mantle Cell Lymphoma-like Neoplasia in Aged Mice.	STAT3
29928398	10.3892/ol.2018.8639	2018	Hydrogen-rich solution attenuates myocardial injury caused by cardiopulmonary bypass in rats via the Janus-activated kinase 2/signal transducer and activator of transcription 3 signaling pathway.	STAT3
29992138	10.1155/2018/3574534	2018	Identification of Hub Genes and Key Pathways Associated with Two Subtypes of Diffuse Large B-Cell Lymphoma Based on Gene Expression Profiling via Integrated Bioinformatics.	STAT3
30013646	10.3892/ol.2018.8899	2018	Pachymic acid inhibits growth and induces cell cycle arrest and apoptosis in gastric cancer SGC-7901 cells.	STAT3
30020405	10.1093/abbs/gmy076	2018	PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression.	STAT3
30054295	10.1182/blood-2018-01-829424	2018	Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma.	STAT3
30093402	10.1182/blood-2018-03-838524	2018	Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with <i>DUSP22</i> rearrangements.	STAT3
30099568	10.1007/s00277-018-3439-x	2018	Novel synthetic 4-chlorobenzoyl berbamine inhibits c-Myc expression and induces apoptosis of diffuse large B cell lymphoma cells.	STAT3
30132572	10.3892/mmr.2018.9420	2018	Alpinetin inhibits proliferation and migration of ovarian cancer cells via suppression of STAT3 signaling.	STAT3
30194286	10.12659/MSM.910170	2018	Inhibition of JAK2/STAT3 Signaling Pathway Suppresses Proliferation of Burkitt's Lymphoma Raji Cells via Cell Cycle Progression, Apoptosis, and Oxidative Stress by Modulating HSP70.	STAT3
30209121	10.1182/blood-2018-03-841015	2018	B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma.	STAT3
30209389	10.1038/s41467-018-06134-z	2018	STAT3-coordinated migration facilitates the dissemination of diffuse large B-cell lymphomas.	STAT3
30214513	10.3892/etm.2018.6562	2018	Tanshinone IIA inhibits cell proliferation and tumor growth by downregulating STAT3 in human gastric cancer.	STAT3
30217007	10.3390/cancers10090327	2018	The Role of Signal Transducer and Activator of Transcription 3 (STAT3) and Its Targeted Inhibition in Hematological Malignancies.	STAT3
30217447	10.1016/j.bbrc.2018.09.019	2018	Translocation-generated ITK-FER and ITK-SYK fusions induce STAT3 phosphorylation and CD69 expression.	STAT3
30231940	10.1186/s13045-018-0665-6	2018	JAG1 overexpression contributes to Notch1 signaling and the migration of HTLV-1-transformed ATL cells.	STAT3
30250636	10.18632/oncotarget.26054	2018	JAK inhibitors for refractory lymphoma.	STAT3
30253331	10.1016/j.intimp.2018.09.024	2018	MYD88 L265P mutation promoted malignant B cell resistance against T cell-mediated cytotoxicity via upregulating the IL-10/STAT3 cascade.	STAT3
30257404	10.1016/j.biopha.2018.08.091	2018	The relationship between lncRNA PCGEM1 and STAT3 during the occurrence and development of endometrial carcinoma.	STAT3
30272302	10.3892/or.2018.6711	2018	Taurolidine promotes cell apoptosis by enhancing GRIM‑19 expression in liver cancer.	STAT3
30305518	10.11406/rinketsu.59.2127	2018	[Genetic analysis and its clinical implication in adult T-cell leukemia/lymphoma].	STAT3
30334451	10.4149/neo_2018_180121N44	2018	miR-451a induced apoptosis of Philadelphia chromosome-positive acute lymphoblastic leukemia cells by targeting IL-6R.	STAT3
30335863	10.1371/journal.pone.0206014	2018	Oncogenic mutations in IKKβ function through global changes induced by K63-linked ubiquitination and result in autocrine stimulation.	STAT3
30360879	10.1053/j.seminoncol.2018.07.005	2018	New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs.	STAT3
30384495	10.3390/v10110599	2018	EBV and KSHV Infection Dysregulates Autophagy to Optimize Viral Replication, Prevent Immune Recognition and Promote Tumorigenesis.	STAT3
30390336	10.1002/jcb.28000	2018	Icaritin inhibits glioblastoma cell viability and glycolysis by blocking the IL-6/Stat3 pathway.	STAT3
30405790	10.3892/ol.2018.9475	2018	Ganoderic acid A exerts antitumor activity against MDA-MB-231 human breast cancer cells by inhibiting the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.	STAT3
30410493	10.3389/fimmu.2018.02470	2018	Molecular Control of Follicular Helper T cell Development and Differentiation.	STAT3
30420593	10.1038/s41408-018-0138-8	2018	Prognostic and therapeutic significance of phosphorylated STAT3 and protein tyrosine phosphatase-6 in peripheral-T cell lymphoma.	STAT3
30446007	10.1186/s40425-018-0436-5	2018	STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial.	STAT3
30458835	10.1186/s12967-018-1689-y	2018	Clinicopathologic implication of PD-L1 and phosphorylated STAT3 expression in diffuse large B cell lymphoma.	STAT3
30501694	10.7534/j.issn.1009-2137.2018.06.007	2018	[Effect of IL-8 on the Immune Function of Patients with Acute -Lymphoblastic Leukemia and Its Mechanism].	STAT3
30534553	10.1155/2018/1042597	2018	Bone Marrow Molecular Markers Associated with Relapsed/Refractory Activated B-Cell-Like Diffuse Large B-Cell Lymphoma.	STAT3
30546832	10.18632/oncotarget.26308	2018	Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma.	STAT3
30619766	10.3389/fonc.2018.00632	2018	Glutaminolysis Mediated by MALT1 Protease Activity Facilitates PD-L1 Expression on ABC-DLBCL Cells and Contributes to Their Immune Evasion.	STAT3
30704352	10.1080/25785826.2018.1556030	2018	Chronic active Epstein-Barr virus infection: a bi-faceted disease with inflammatory and neoplastic elements.	STAT3
31949637		2018	Aggressive natural killer cell leukemia mimicking interstitial lung diseases with the activation of the mitogen-activated protein kinase pathway.	STAT3
35547965	10.1039/c8ra05224g	2018	Screening of ferrocenyl-phosphines identifies a gold-coordinated derivative as a novel anticancer agent for hematological malignancies.	STAT3
27924626	10.14670/HH-11-852	2017	Expression of the activation markers Blimp1, Foxp1 and pStat3 in extranodal diffuse large B-cell lymphomas.	STAT3
28009988	10.18632/oncotarget.14032	2017	A neutralized human LMP1-IgG inhibits ENKTL growth by suppressing the JAK3/STAT3 signaling pathway.	STAT3
28069035	10.1186/s13046-016-0476-y	2017	Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation.	STAT3
28082737	10.1038/leu.2017.13	2017	Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL.	STAT3
28344319	10.1038/leu.2017.103	2017	PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma.	STAT3
28356514	10.1073/pnas.1700682114	2017	Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.	STAT3
28414323	10.1038/labinvest.2017.39	2017	Pyrimidine tract-binding protein 1 mediates pyruvate kinase M2-dependent phosphorylation of signal transducer and activator of transcription 3 and oncogenesis in anaplastic large cell lymphoma.	STAT3
28483518	10.1016/j.bbrc.2017.05.031	2017	STAT3 mediates multidrug resistance of Burkitt lymphoma cells by promoting antioxidant feedback.	STAT3
28522550	10.1042/BSR20170186	2017	Suppression of microRNA-135b-5p protects against myocardial ischemia/reperfusion injury by activating JAK2/STAT3 signaling pathway in mice during sevoflurane anesthesia.	STAT3
28529032	10.1016/j.ebiom.2017.04.037	2017	Synergistic Cytotoxicity of Lenalidomide and Dexamethasone in Mantle Cell Lymphoma via Cereblon-dependent Targeting of the IL-6/STAT3/PI3K Axis.	STAT3
28534932	10.3892/mmr.2017.6583	2017	Inhibition of prostate cancer RM1 cell growth in vitro by hydroxyapatite nanoparticle‑delivered short hairpin RNAs against Stat3.	STAT3
28535087	10.1080/10428194.2017.1324154	2017	Cytotoxic T cells in chronic idiopathic neutropenia express restricted antigen receptors.	STAT3
28599489	10.3892/ol.2017.6073	2017	Maslinic acid suppresses the growth of human gastric cells by inducing apoptosis via inhibition of the interleukin-6 mediated Janus kinase/signal transducer and activator of transcription 3 signaling pathway.	STAT3
28617558		2017	Up-regulation of miR-124 inhibits invasion and proliferation of prostate cancer cells through mediating JAK-STAT3 signaling pathway.	STAT3
28619949	10.1189/jlb.5MA1116-453RR	2017	Expansion and activation of granulocytic, myeloid-derived suppressor cells in childhood precursor B cell acute lymphoblastic leukemia.	STAT3
28623282	10.1038/s41598-017-03967-4	2017	A Nationwide Study of Severe and Protracted Diarrhoea in Patients with Primary Immunodeficiency Diseases.	STAT3
28640256	10.1038/cddis.2017.291	2017	MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines.	STAT3
28644106	10.1902/jop.2017.170116	2017	Viability and Osteogenic Differentiation of Human Periodontal Ligament Progenitor Cells Are Maintained After Incubation With Porphyromonas gingivalis Protein Extract.	STAT3
28653223	10.1007/s10495-017-1391-1	2017	Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma.	STAT3
28656237	10.3892/mmr.2017.6865	2017	Matrine increases the inhibitory effects of afatinib on H1975 cells via the IL‑6/JAK1/STAT3 signaling pathway.	STAT3
28713965	10.3892/mmr.2017.6989	2017	Dihydroartemisinin and gefitinib synergistically inhibit NSCLC cell growth and promote apoptosis via the Akt/mTOR/STAT3 pathway.	STAT3
28716895	10.1158/0008-5472.CAN-16-0342	2017	CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity.	STAT3
28756223	10.1016/j.bbrc.2017.07.139	2017	BEBT-908: A novel potent PI3K/HDAC inhibitor against diffuse large B-cell lymphoma.	STAT3
28806414	10.1371/journal.pone.0183003	2017	Alpha-tocopherol attenuates the anti-tumor activity of crizotinib against cells transformed by NPM-ALK.	STAT3
28811825	10.1155/2017/4218468	2017	Ethanol Extract of <i>Mylabris phalerata</i> Inhibits M2 Polarization Induced by Recombinant IL-4 and IL-13 in Murine Macrophages.	STAT3
28837676	10.1371/journal.pone.0183516	2017	ALK signaling cascade confers multiple advantages to glioblastoma cells through neovascularization and cell proliferation.	STAT3
28842424	10.1096/fj.201700120RR	2017	Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathways.	STAT3
28848064	10.4049/jimmunol.1700106	2017	Integrated STAT3 and Ikaros Zinc Finger Transcription Factor Activities Regulate Bcl-6 Expression in CD4<sup>+</sup> Th Cells.	STAT3
28870600	10.1016/j.yexcr.2017.08.036	2017	Interleukin 10 enhanced CD8+ T cell activity and reduced CD8<sup>+</sup> T cell apoptosis in patients with diffuse large B cell lymphoma.	STAT3
28910419	10.1371/journal.ppat.1006597	2017	IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways.	STAT3
28950914	10.1186/s13046-017-0601-6	2017	Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway.	STAT3
28964970	10.1016/j.cellsig.2017.09.020	2017	Metformin triggers apoptosis in PEL cells and alters bortezomib-induced Unfolded Protein Response increasing its cytotoxicity and inhibiting KSHV lytic cycle activation.	STAT3
29022919	10.1038/cddis.2017.472	2017	DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway.	STAT3
29029457	10.18632/oncotarget.19936	2017	Prognostic relevance of protein expression, clinical factors, and <i>MYD88</i> mutation in primary bone lymphoma.	STAT3
29033545	10.2147/DDDT.S135993	2017	Downregulation of A20 increases the cytotoxicity of IFN-γ in hepatocellular carcinoma cells.	STAT3
29039526	10.3892/mmr.2017.7771	2017	Promoting effects of IL‑23 on myocardial ischemia and reperfusion are associated with increased expression of IL‑17A and upregulation of the JAK2‑STAT3 signaling pathway.	STAT3
29043002	10.3892/etm.2017.4934	2017	Humanin analogue, S14G-humanin, has neuroprotective effects against oxygen glucose deprivation/reoxygenation by reactivating Jak2/Stat3 signaling through the PI3K/AKT pathway.	STAT3
29045271	10.1097/CAD.0000000000000552	2017	Rhabdomyosarcoma cells are susceptible to cell death by LDK378 alone or in combination with sorafenib independently of anaplastic lymphoma kinase status.	STAT3
29131834	10.1371/journal.pone.0187722	2017	Plasma microRNA profiling: Exploring better biomarkers for lymphoma surveillance.	STAT3
29133756	10.4103/0366-6999.218016	2017	Signal Transducer and Activator of Transcription 3 for the Differentiation of Hepatocellular Carcinoma from Cirrhosis.	STAT3
29142404	10.4103/pm.pm_13_17	2017	Chalepin: A Compound from <i>Ruta angustifolia</i> L. Pers Exhibits Cell Cycle Arrest at S phase, Suppresses Nuclear Factor-Kappa B (NF-κB) Pathway, Signal Transducer and Activation of Transcription 3 (STAT3) Phosphorylation and Extrinsic Apoptotic Pathway in Non-small Cell Lung Cancer Carcinoma (A549).	STAT3
29179721	10.1186/s13046-017-0632-z	2017	Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death.	STAT3
29228427	10.26355/eurrev_201711_13832	2017	MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway.	STAT3
29228628	10.18632/oncotarget.22178	2017	Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling.	STAT3
29262599	10.18632/oncotarget.21790	2017	Fusion of the genes ataxin 2 like, <i>ATXN2L</i>, and Janus kinase 2, <i>JAK2</i>, in cutaneous CD4 positive T-cell lymphoma.	STAT3
29279550	10.3960/jslrt.17023	2017	Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects.	STAT3
29285175	10.3892/etm.2017.5329	2017	Quercetin prevents alcohol-induced liver injury through targeting of PI3K/Akt/nuclear factor-κB and STAT3 signaling pathway.	STAT3
29340070	10.18632/oncotarget.22847	2017	A novel orally available Syk/Src/Jak2 inhibitor, SKLB-850, showed potent anti-tumor activities in B cell lymphoma (BCL) models.	STAT3
26738536	10.1182/blood-2015-08-662353	2016	Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma.	STAT3
26789110	10.18632/oncotarget.6916	2016	Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.	STAT3
26815506	10.1007/s13277-016-4861-0	2016	Curcumin analogue, A13, exhibits anti-leukemia effect via inhibiting STAT3.	STAT3
26983850	10.1182/blood-2015-10-678706	2016	Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism.	STAT3
27132469	10.1016/j.ccell.2016.03.026	2016	Tight Junction Protein 1 Modulates Proteasome Capacity and Proteasome Inhibitor Sensitivity in Multiple Myeloma via EGFR/JAK1/STAT3 Signaling.	STAT3
27198716	10.3324/haematol.2016.146118	2016	Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma.	STAT3
27268052	10.1074/jbc.M116.736868	2016	Synthetic Lethal Screen Demonstrates That a JAK2 Inhibitor Suppresses a BCL6-dependent IL10RA/JAK2/STAT3 Pathway in High Grade B-cell Lymphoma.	STAT3
27371847		2016	[Astaxanthin inhibits proliferation and promotes apoptosis of A549 lung cancer cells via blocking JAK1/STAT3 pathway].	STAT3
27436361	10.1126/scisignal.aad8953	2016	ROCK2 signaling is required to induce a subset of T follicular helper cells through opposing effects on STATs in autoimmune settings.	STAT3
27564404	10.1111/cas.13065	2016	An IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphoma.	STAT3
27633398	10.3892/or.2016.5091	2016	WP1066 exhibits antitumor efficacy in nasal‑type natural killer/T-cell lymphoma cells through downregulation of the STAT3 signaling pathway.	STAT3
24793791	10.1038/onc.2014.109	2015	Phosphorylated STAT3 physically interacts with NPM and transcriptionally enhances its expression in cancer.	STAT3
25586472	10.1038/ncomms7025	2015	Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.	STAT3
25612622	10.1182/blood-2014-07-588970	2015	Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma.	STAT3
25684945	10.3748/wjg.v21.i6.1804	2015	Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3.	STAT3
25704763	10.1002/ijc.29494	2015	A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.	STAT3
25717101	10.1128/JVI.00121-15	2015	Cellular STAT3 functions via PCBP2 to restrain Epstein-Barr Virus lytic activation in B lymphocytes.	STAT3
25977172		2015	Effect of STAT3 inhibition on the metabolic switch in a highly STAT3-activated lymphoma cell line.	STAT3
25984943	10.1371/journal.pone.0127243	2015	Ratios of Four STAT3 Splice Variants in Human Eosinophils and Diffuse Large B Cell Lymphoma Cells.	STAT3
26080800	10.1007/s11060-015-1843-9	2015	STAT3 activation is associated with cerebrospinal fluid interleukin-10 (IL-10) in primary central nervous system diffuse large B cell lymphoma.	STAT3
26184999	10.1016/j.canlet.2015.07.006	2015	Tyrosine kinase inhibitor tyrphostin AG490 triggers both apoptosis and autophagy by reducing HSF1 and Mcl-1 in PEL cells.	STAT3
26244872	10.18632/oncotarget.4111	2015	Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.	STAT3
26245900	10.1074/jbc.M115.657833	2015	The Mutant KRAS Gene Up-regulates BCL-XL Protein via STAT3 to Confer Apoptosis Resistance That Is Reversed by BIM Protein Induction and BCL-XL Antagonism.	STAT3
26255115	10.1016/j.biocel.2015.08.002	2015	Downregulation of STAT3 phosphorylation enhances tumoricidal effect of IL-15-activated dendritic cell against doxorubicin-resistant lymphoma and leukemia via TNF-α.	STAT3
26430964	10.18632/oncotarget.5763	2015	Overexpression of Bcl-2 induces STAT-3 activation via an increase in mitochondrial superoxide.	STAT3
26500281	10.1042/BSR20150165	2015	Induction of caspase-dependent extrinsic apoptosis by apigenin through inhibition of signal transducer and activator of transcription 3 (STAT3) signalling in HER2-overexpressing BT-474 breast cancer cells.	STAT3
26565811	10.18632/oncotarget.6300	2015	Loss of function mutations in PTPN6 promote STAT3 deregulation via JAK3 kinase in diffuse large B-cell lymphoma.	STAT3
26582900	10.1126/scitranslmed.aac5272	2015	AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer.	STAT3
26675719	10.1038/nature16449	2015	Germline variant FGFR4 p.G388R exposes a membrane-proximal STAT3 binding site.	STAT3
23841503	10.3109/10428194.2013.824077	2014	Expression of microRNA-1234 related signal transducer and activator of transcription 3 in patients with diffuse large B-cell lymphoma of activated B-cell like type from high and low infectious disease areas.	STAT3
23975180	10.3324/haematol.2013.088286	2014	STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma.	STAT3
24497534	10.1182/blood-2013-12-544809	2014	GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features.	STAT3
24892807	10.1172/JCI73174	2014	CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells.	STAT3
25070240	10.1186/1476-4598-13-181	2014	ISL-1 is overexpressed in non-Hodgkin lymphoma and promotes lymphoma cell proliferation by forming a p-STAT3/p-c-Jun/ISL-1 complex.	STAT3
25110240	10.5146/tjpath.2014.01269	2014	The expression of STAT3, BCL-XL and MMP-2 proteins in colon adenocarcinomas and their relationship with prognostic factors.	STAT3
25242136	10.3892/mmr.2014.2581	2014	Cucurbitacin B inhibits proliferation and induces apoptosis via STAT3 pathway inhibition in A549 lung cancer cells.	STAT3
25275020		2014	STAT3 activation and infiltration of eosinophil granulocytes in mycosis fungoides.	STAT3
22967991	10.1093/annonc/mds209	2013	A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome.	STAT3
23563237	10.1038/leu.2013.104	2013	STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia.	STAT3
23599149	10.1038/modpathol.2013.73	2013	ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements.	STAT3
23681230	10.1038/cddis.2013.159	2013	SIRT1 activation enhances HDAC inhibition-mediated upregulation of GADD45G by repressing the binding of NF-κB/STAT3 complex to its promoter in malignant lymphoid cells.	STAT3
23716595	10.1128/MCB.01620-12	2013	STAT5 outcompetes STAT3 to regulate the expression of the oncogenic transcriptional modulator BCL6.	STAT3
23740979	10.1128/JVI.02976-12	2013	Kaposi's sarcoma-associated herpesvirus kaposin B induces unique monophosphorylation of STAT3 at serine 727 and MK2-mediated inactivation of the STAT3 transcriptional repressor TRIM28.	STAT3
23741012	10.1182/blood-2012-11-465252	2013	STAT3 mediates oncogenic addiction to TEL-AML1 in t(12;21) acute lymphoblastic leukemia.	STAT3
23750211	10.1371/journal.pone.0064678	2013	Signal transducer and activator of transcription-3 induces microRNA-155 expression in chronic lymphocytic leukemia.	STAT3
23768868	10.1016/j.leukres.2013.05.003	2013	Polymorphisms in JAK/STAT signaling pathway genes and risk of non-Hodgkin lymphoma.	STAT3
23830147	10.1016/j.jaci.2013.05.029	2013	Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function.	STAT3
23861822	10.1371/journal.pone.0067851	2013	A novel missense (M206K) STAT3 mutation in diffuse large B cell lymphoma deregulates STAT3 signaling.	STAT3
23966384	10.1128/JVI.01762-13	2013	Signal transducer and activator of transcription 3 limits Epstein-Barr virus lytic activation in B lymphocytes.	STAT3
23995109	10.3960/jslrt.53.127	2013	Role of Stat3 activation in cell-cell interaction between B-cell lymphoma and macrophages: the in vitro study.	STAT3
24142927	10.1534/g3.113.007674	2013	STAT3 targets suggest mechanisms of aggressive tumorigenesis in diffuse large B-cell lymphoma.	STAT3
21818116	10.1038/leu.2011.198	2012	Constitutive activation of STAT3 in Sézary syndrome is independent of SHP-1.	STAT3
21938013	10.1038/jid.2011.293	2012	Autocrine IL-21 stimulation is involved in the maintenance of constitutive STAT3 activation in Sézary syndrome.	STAT3
22116549	10.1038/leu.2011.340	2012	Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy.	STAT3
22126101	10.3109/10428194.2011.645212	2012	Investigation and analysis of single nucleotide polymorphisms in Janus kinase/signal transducer and activator of transcription genes with leukemia.	STAT3
22491065	10.1038/icb.2012.17	2012	IL-6 triggers IL-21 production by human CD4+ T cells to drive STAT3-dependent plasma cell differentiation in B cells.	STAT3
22656398	10.1016/j.jfma.2010.10.002	2012	Interleukin-27 and interleukin-12 augment activation of distinct cord blood natural killer cells responses via STAT3 pathways.	STAT3
22735740	10.1039/c2mb25120e	2012	Impaired JAK2-induced activation of STAT3 in failing human myocytes.	STAT3
22745305	10.1182/blood-2011-12-399030	2012	S1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma.	STAT3
22751495	10.1097/MD.0b013e31825f95b9	2012	Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.	STAT3
23018644	10.1182/blood-2012-05-428466	2012	Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOP.	STAT3
21085192	10.1038/jid.2010.349	2011	MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome.	STAT3
21346774	10.1038/jid.2011.27	2011	Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3/Stat3 signaling pathway.	STAT3
21415216	10.1158/1078-0432.CCR-10-2798	2011	Role of ERK-BIM and STAT3-survivin signaling pathways in ALK inhibitor-induced apoptosis in EML4-ALK-positive lung cancer.	STAT3
21806788	10.1186/1756-8722-4-31	2011	High nuclear expression of STAT3 is associated with unfavorable prognosis in diffuse large B-cell lymphoma.	STAT3
22104307	10.3960/jslrt.51.93	2011	M2 macrophage/microglial cells induce activation of Stat3 in primary central nervous system lymphoma.	STAT3
19889776	10.1128/JVI.01745-09	2010	Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors.	STAT3
19968719	10.1111/j.1751-553X.2009.01204.x	2010	Frequent STAT3 activation is associated with Mcl-1 expression in nasal NK-cell lymphoma.	STAT3
20015877	10.3324/haematol.2009.014050	2010	C/EBPβ expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway.	STAT3
20133729	10.1073/pnas.0909086107	2010	STAT3 is a substrate of SYK tyrosine kinase in B-lineage leukemia/lymphoma cells exposed to oxidative stress.	STAT3
20213502	10.2478/s11658-010-0008-2	2010	STAT3 knockdown by siRNA induces apoptosis in human cutaneous T-cell lymphoma line Hut78 via downregulation of Bcl-xL.	STAT3
20438785	10.1016/j.humimm.2010.04.004	2010	Polymorphisms in innate immunity genes and risk of childhood leukemia.	STAT3
20446017	10.1007/s11060-010-0188-7	2010	Expression of signal transducer and activator of transcription 3 (STAT3) in primary central nervous system diffuse large B-cell lymphoma: a retrospective analysis of 17 cases.	STAT3
20663948	10.3324/haematol.2009.019745	2010	Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma.	STAT3
20716621	10.1158/1055-9965.EPI-10-0389	2010	Genetic polymorphisms in adaptive immunity genes and childhood acute lymphoblastic leukemia.	STAT3
20802378	10.1097/FPC.0b013e32833deb16	2010	A multiplex MALDI-TOF MS approach facilitates genotyping of DNA from formalin-fixed paraffin-embedded tumour specimens.	STAT3
20974051		2010	Gene regulation by BCL3 in a cervical cancer cell line.	STAT3
18755494	10.1016/j.humpath.2008.06.009	2009	Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion.	STAT3
19251695	10.1074/jbc.M807761200	2009	STAT3-stathmin interactions control microtubule dynamics in migrating T-cells.	STAT3
19421230	10.1038/leu.2009.91	2009	STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma.	STAT3
19608866	10.2353/ajpath.2009.080982	2009	IL-21 contributes to JAK3/STAT3 activation and promotes cell growth in ALK-positive anaplastic large cell lymphoma.	STAT3
19626047	10.1038/leu.2009.139	2009	IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing.	STAT3
17951530	10.1182/blood-2007-04-087734	2008	Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas.	STAT3
18160665	10.1182/blood-2007-09-111948	2008	Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma.	STAT3
18354204	10.4049/jimmunol.180.7.4805	2008	STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation.	STAT3
18483262	10.1158/0008-5472.CAN-07-6091	2008	Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphoma.	STAT3
18636124	10.1371/journal.pone.0002816	2008	Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.	STAT3
18684866	10.1182/blood-2008-01-134783	2008	Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3alpha.	STAT3
19074878	10.1158/0008-5472.CAN-08-2121	2008	The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?	STAT3
19088198	10.1073/pnas.0810958105	2008	Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1).	STAT3
17151100	10.1128/JVI.01769-06	2007	Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.	STAT3
18024124	10.1016/j.micinf.2007.09.008	2007	Integration of HIV-1 caused STAT3-associated B cell lymphoma in an AIDS patient.	STAT3
16364321	10.1016/j.febslet.2005.11.057	2006	Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA.	STAT3
16732314	10.1038/sj.onc.1209711	2006	BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription.	STAT3
16825495	10.1182/blood-2006-04-017434	2006	Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma.	STAT3
16861352	10.1182/blood-2005-08-007377	2006	STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes.	STAT3
17015686	10.4049/jimmunol.177.8.5032	2006	A preferential role for STAT5, not constitutively active STAT3, in promoting survival of a human lymphoid tumor.	STAT3
17225522		2006	[Expression and its significance of STAT3, STAT5, Survivin and Ki67 in nasal NK/T cell lymphoma].	STAT3
15870198	10.1073/pnas.0501959102	2005	STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes.	STAT3
15895073	10.1038/nm1249	2005	Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target.	STAT3
15912144	10.1038/sj.leu.2403750	2005	STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis.	STAT3
16306601	10.1128/JVI.79.24.15302-15313.2005	2005	Respiratory syncytial virus-inducible BCL-3 expression antagonizes the STAT/IRF and NF-kappaB signaling pathways by inducing histone deacetylase 1 recruitment to the interleukin-8 promoter.	STAT3
12969979	10.1182/blood-2003-04-1048	2004	Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation.	STAT3
14968112	10.1038/sj.onc.1207398	2004	Identification of NPM-ALK interacting proteins by tandem mass spectrometry.	STAT3
15141228	10.1038/sj.leu.2403385	2004	In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3.	STAT3
15161657	10.1016/S0002-9440(10)63781-9	2004	Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.	STAT3
15163742	10.1128/JVI.78.12.6489-6497.2004	2004	Activation of Stat3 transcription factor by Herpesvirus saimiri STP-A oncoprotein.	STAT3
15207733	10.1016/j.bbrc.2004.05.162	2004	Herpesvirus saimiri STP A11 protein interacts with STAT3 and stimulates its transcriptional activity.	STAT3
12393476	10.1182/blood-2002-07-2130	2003	Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma.	STAT3
11751994	10.4049/jimmunol.168.1.466	2002	Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma.	STAT3
12389630	10.1080/1042819022386716	2002	Role of the leukemia-associated transcription factor STAT3 in platelet physiology.	STAT3
11021801	10.1126/science.290.5489.144	2000	Regulation of STAT3 by direct binding to the Rac1 GTPase.	STAT3
10037026	10.3109/10428199909167389	1999	Differential substrate recognition capabilities of Janus family protein tyrosine kinases within the interleukin 2 receptor (IL2R) system: Jak3 as a potential molecular target for treatment of leukemias with a hyperactive Jak-Stat signaling machinery.	STAT3
